1.The Association Between the Serum Sodium Level and the Severity of Complications in Liver Cirrhosis.
Jong Hoon KIM ; June Sung LEE ; Seuk Hyun LEE ; Won Ki BAE ; Nam Hoon KIM ; Kyung Ah KIM ; Young Soo MOON
The Korean Journal of Internal Medicine 2009;24(2):106-112
BACKGROUND/AIMS: Dilutional hyponatremia associated with liver cirrhosis is caused by impaired free water clearance. Several studies have shown that serum sodium levels correlate with survival in cirrhotic patients. Little is known, however, regarding the relationship between the degree of dilutional hyponatremia and development of cirrhotic complications. The aim of this study was to evaluate the association between the serum sodium level and the severity of complications in liver cirrhosis. METHODS: Data of inpatients with cirrhotic complications were collected retrospectively. The serum sodium levels and severity of complications of 188 inpatients were analyzed. RESULTS: The prevalence of dilutional hyponatremia, classified as serum sodium concentrations of < or =135 mmol/L, < or =130 mmol/L, and < or =125 mmol/L, were 20.8%, 14.9%, and 12.2%, respectively. The serum sodium level was strongly associated with the severity of liver function impairment as assessed by Child-Pugh and MELD scores (p<0.0001). Even a mild hyponatremia with a serum sodium concentration of 131-135 mmol/L was associated with severe complications. Sodium levels less than 130 mmol/L indicated the existence of massive ascites (OR, 2.685; CI, 1.316-5.477; p=0.007), grade III or higher hepatic encephalopathy (OR, 5.891; CI, 1.490-23.300; p=0.011), spontaneous bacterial peritonitis (OR, 2.562; CI, 1.162-5.653; p=0.020), and hepatic hydrothorax (OR, 5.723; CI, 1.889-17.336; p=0.002). CONCLUSIONS: Hyponatremia, especially serum levels < or =130 mmol/L, may indicate the existence of severe complications associated with liver cirrhosis
Adult
;
Aged
;
Ascites/blood/etiology
;
Biological Markers/blood
;
Female
;
Hepatic Encephalopathy/blood/etiology
;
Humans
;
Hydrothorax/blood/etiology
;
Hyponatremia/blood/*etiology/mortality
;
Kaplan-Meiers Estimate
;
Liver Cirrhosis/blood/*complications/mortality/physiopathology
;
Liver Function Tests
;
Logistic Models
;
Male
;
Middle Aged
;
Peritonitis/blood/etiology
;
Predictive Value of Tests
;
Retrospective Studies
;
Risk Assessment
;
Severity of Illness Index
;
Sodium/*blood
;
Time Factors
2.Hepatic Venous Pressure Gradient Predicts Long-Term Mortality in Patients with Decompensated Cirrhosis.
Tae Yeob KIM ; Jae Gon LEE ; Joo Hyun SOHN ; Ji Yeoun KIM ; Sun Min KIM ; Jinoo KIM ; Woo Kyoung JEONG
Yonsei Medical Journal 2016;57(1):138-145
PURPOSE: The present study aimed to investigate the role of hepatic venous pressure gradient (HVPG) for prediction of long-term mortality in patients with decompensated cirrhosis. MATERIALS AND METHODS: Clinical data from 97 non-critically-ill cirrhotic patients with HVPG measurements were retrospectively and consecutively collected between 2009 and 2012. Patients were classified according to clinical stages and presence of ascites. The prognostic accuracy of HVPG for death, survival curves, and hazard ratios were analyzed. RESULTS: During a median follow-up of 24 (interquartile range, 13-36) months, 22 patients (22.7%) died. The area under the receiver operating characteristics curves of HVPG for predicting 1-year, 2-year, and overall mortality were 0.801, 0.737, and 0.687, respectively (all p<0.01). The best cut-off value of HVPG for predicting long-term overall mortality in all patients was 17 mm Hg. The mortality rates at 1 and 2 years were 8.9% and 19.2%, respectively: 1.9% and 11.9% with HVPG < or =17 mm Hg and 16.2% and 29.4% with HVPG >17 mm Hg, respectively (p=0.015). In the ascites group, the mortality rates at 1 and 2 years were 3.9% and 17.6% with HVPG < or =17 mm Hg and 17.5% and 35.2% with HVPG >17 mm Hg, respectively (p=0.044). Regarding the risk factors for mortality, both HVPG and model for end-stage liver disease were positively related with long-term mortality in all patients. Particularly, for the patients with ascites, both prothrombin time and HVPG were independent risk factors for predicting poor outcomes. CONCLUSION: HVPG is useful for predicting the long-term mortality in patients with decompensated cirrhosis, especially in the presence of ascites.
Adult
;
Aged
;
Ascites/mortality
;
Female
;
Hepatic Veins/*physiopathology
;
Humans
;
Kaplan-Meier Estimate
;
Liver Cirrhosis/blood/complications/diagnosis/*mortality/*physiopathology
;
Liver Failure/diagnosis/*mortality/physiopathology
;
Male
;
Middle Aged
;
Predictive Value of Tests
;
Prognosis
;
Proportional Hazards Models
;
ROC Curve
;
Retrospective Studies
;
Risk Factors
;
Severity of Illness Index
;
Venous Pressure